Eli Lilly, the makers of tirzepatide—which they sell as Mounjaro for diabetes and Zepbound for weight loss— announced recently that in its longest study yet on tirzepatide, the drug reduced the risk of people with prediabetes moving on to develop diabetes by 94% compared to those taking a placebo.

The manufacturer of Ozempic is testing amycretin, an experimental weight-loss pill that appears to help people quickly shed pounds.

Pill Helps People Lose Weight, Combines GLP-1 With Other Drug By Dennis Thompson HealthDay Reporter WEDNESDAY, (HealthDay News) -- An experimental weight-loss pill appears to help people quickly shed pounds,